Arif Akyıldız

14PUBLICATIONS
77CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapyHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Feb 27, 2026
Prognostic Value of Baseline Sarcopenia and Adipose Tissue Indices in HR+/HER2- Metastatic Breast Cancer Treated with CDK4/6 Inhibitors: A Retrospective Cohort Study.

Latif Karahan, Arif Akyildiz, Taha Koray Sahin

|Feb 27, 2026
Efficacy, Safety, and Survival Outcomes of Immune Checkpoint Inhibitors in Patients with Mismatch Repair-Deficient Colorectal Cancer: A Retrospective, Multicenter Study.

Mehmet Cihan İcli, Deniz Can Guven, Arif Akyildiz

|Sep 27, 2025
Comprehensive Review of Transarterial Chemoembolization Plus Systemic Therapy in Advanced Hepatocellular Carcinoma.

Arif Akyildiz, Betul Gok Yavuz, Rashad Ismayilov

|Jul 10, 2025
Prognostic and predictive significance of the pan-immune-inflammation value in endometrial cancer patients undergoing adjuvant therapy.

Elvin Chalabıyev, Rashad Ismayılov, Fatih Kus

|Jun 27, 2025
"Pre-Treatment" and "Post-Treatment" Systemic Inflammatory Markers: Is There Any Prognostic Role for Metastatic Cervical Cancer on Bevacizumab Containing Treatment?

Serkan Yaşar, Ahmet Kadıoğlu, Arif Akyildiz

|Apr 23, 2025
Does high PD-L1 expression reduce the risk of relapse after definitive surgery in patients with oral cavity cancer?

Parvin Babayev, Rashad Ismayilov, Oguz Kuscu

Pageof 3

Frequent Collaborators

7 joint publications

Rashad Ismayılov

6 joint publications

Deniz Can Guven

3 joint publications

Hasan Cagri Yıldırım

3 joint publications

Zafer Arık